Tissue repair processes are characterized by the biphasic recruitment of distinct subpopulations of blood monocytes, including classical ("inflammatory") monocytes (IMs, Ly6C hi Gr1 + CX3CR1 lo ) and non-classical anti-inflammatory monocytes (AMs, Ly6C lo Gr1 -CX3CR1 hi ). Drug eluting biomaterial implants can be used to tune the endogenous repair process by the preferential recruitment of pro-regenerative cells. To enhance recruitment of AMs during inflammatory injury, a novel N-desulfated heparin-containing poly(ethylene glycol) diacrylate (PEG-DA) hydrogel was engineered to deliver exogenous stromal derived factor-1α (SDF-1α), utilizing the natural capacity of heparin to sequester and release growth factors. SDF-1α released from the hydrogels maintained its bioactivity and stimulated chemotaxis of bone marrow cells in vitro. Intravital microscopy and flow cytometry demonstrated that SDF-1α hydrogels implanted in a murine dorsal skinfold window chamber promoted spatially-localized recruitment of AMs relative to unloaded internal control hydrogels. SDF-1α delivery stimulated arteriolar remodeling that was correlated with AM enrichment in the injury niche. SDF-1α, but not unloaded control hydrogels, supported sustained arteriogenesis and microvascular network growth through 7 days. The recruitment of AMs correlated with parameters of vascular remodeling suggesting that tuning the innate immune response by biomaterial SDF-1α release is a promising strategy for promoting vascular remodeling in a spatially controlled manner.
Introduction
Monocytes are a heterogeneous population of cells that are dynamically recruited to damaged tissues to support injury repair, tissue remodeling, and regeneration [1] [2] [3] [4] [5] . Circulating blood monocytes are found in at least two phenotypic states, the classical "inflammatory" and the non-classical "anti-inflammatory" monocyte. Inflammatory monocytes (IMs), CD45 + CD11b + Ly6C hi Gr1 + CX3CR1 low in mice and CD14 + CD16monocytes in humans, are mobilized from bone marrow (BM) and spleen in response to injury and subsequently recruited to sites of inflammation to expand peripheral mononuclear phagocytes [6, 7] . Anti-inflammatory monocytes (AMs), CD45 + CD11b + Ly6C low Gr1 -CX3CR1 high in mice and CD14 low CD16 + monocytes in humans, patrol the luminal side of endothelium at steady state and are associated with proregenerative activities [8] . Implications for understanding the division of labor among monocyte subpopulations and their progeny during tissue repair are far-reaching. Injuries such as myocardial infarct produce coordinated chemokine expression profiles to recruit and position IMs and AMs sequentially, exploiting the phagocytic and proteolytic activities of IMs in early stages post-infarct and the anti-inflammatory/pro-angiogenic properties of AMs in later healing stages [9] [10] [11] . Key regulatory roles for functionally distinct monocyte subsets and their progeny have been described in numerous other models including bone formation [5, 12] , spinal cord injury healing [13, 14] , limb regrowth [15] , pathogen clearance, embryonic development, and tissue homeostasis [16] . A further understanding of the mechanisms regulating the kinetics and activities of these two monocyte populations during normal wound healing will advance therapeutic targeting of desired cells and regulation of the "injury niche" to support their function within regenerating tissue.
Formation of stable vascular networks during wound repair supplies oxygen and nutrients required for regeneration or biomaterial/tissue implant integration. Vascular remodeling occurs through the complementary processes of angiogenesis (growth of new vessels from existing vascular network) and arteriogenesis (structural expansion of arteriolar conduits to allow increased perfusion). Recruitment and retention of leukocytes by soluble chemotactic gradients within the injury niche is a key determinant of microvascular growth and remodeling [17] [18] [19] [20] . Notably, the perivascular positioning of monocytes is a hallmark of the angiogenic program induced by growth factors such as vascular endothelial growth factor (VEGF) [21] . Stromal derived factor-1α (SDF-1α) is a CXC family chemokine that is increased in tissue after injury and mediates the recruitment of innate immune cells that directly and indirectly participate in the growth of microvascular networks. SDF-1α signals through its cognate G-protein coupled receptor CXC chemokine receptor type 4 (CXCR4), which is highly expressed on immune cells and several known adult stem/progenitor cell sources, including mesenchymal stem cells, hematopoietic stem cells, and endothelial progenitor cells among others [22] [23] [24] . Previous reports suggest a prominent role for the cell surface receptor CXCR4 in regulating monocyte retention and tissue distribution following tissue damage [20, 25, 26] . We have also observed that AMs in particular may be functionally distinguished from IMs by their increased CXCR4-mediated chemotaxis and that selective recruitment of AMs along peri-implant arterioles promotes growth and maturation of microvessel networks in both skin and muscle injury models [17, 19] .
In this study, we investigate how localized presentation of SDF-1α from engineered hydrogels impacts the recruitment and strategic distribution of circulating monocytes populations during sterile inflammatory wound healing and vascular remodeling. We have shown previously that particular derivatives of the glycosaminoglycan (GAG) heparin can protect growth factors such as BMP-2 from denaturing conditions, and that heparin-based biomaterials enable sustained presentation of biomolecular cargo and decrease the amount of growth factor necessary to achieve the same physiological response as bolus delivery [27] [28] [29] . Heparin enhances the loading of growth factor cargo into biomaterials and increased heparin content in the material can enhance the amount of growth factor released, likely by preventing denaturation of the growth factor within the carrier [29] . Thus, heparin derivatives are an excellent choice for sustained delivery of heparin-binding proteins such as SDF-1α [30] . To enable safe in vivo use of heparin-based biomaterials in present and future studies, we employed a desulfated heparin formulation that exhibits very low anticoagulant activity and extends the half-life of growth factors in solution and in delivery systems [28, 29, [31] [32] [33] [34] [35] [36] . In this study, hydrogel matrices were fabricated by cross-linking N-desulfated heparin methacrylamide and poly(ethylene glycol) diacrylate (PEG-DA) (hereafter called Hep -N hydrogels) and loaded with recombinant murine SDF-1α in the presence of albumin as an additional stabilizing factor [37, 38] . Release of SDF-1α from Hep -N hydrogels was sustained over at least 3 days in vitro and retained the ability to induce chemotaxis of primary bone marrow-derived cells. The murine dorsal skinfold window chamber, a model of inflammatory vascular remodeling, was utilized to longitudinally test the in vivo effects of affinity-based delivery of SDF-1α on recruitment of circulating monocytes and associated microvascular network regeneration and expansion. SDF-1α-loaded Hep -N hydrogels were co-implanted in the dorsal skin window chamber with internal control hydrogels not containing SDF-1α. Multiple types of analysis, including intra-vital microscopy, flow cytometry, and whole-mount immunostaining of dorsal skin tissues show that SDF-1α presentation from Hep -N hydrogels results in highly localized recruitment of bone marrowderived monocytes (predominantly AMs) to the injury niche without significantly altering the distribution of cells adhered at the hydrogel implant and tissue interface. SDF-1αinduced recruitment of host cells significantly increased the caliber and number of perihydrogel microvessels versus internal controls, suggesting an exciting potential of the growth factor-releasing Hep -N hydrogel technology to locally tune the interaction of innate immune cell populations with the injury niche to promote regeneration.
Materials and Methods

Heparin chemical modification
Heparin sodium salt (Sigma) was reconstituted with distilled, deionized water (ddH 2 O) at 10mg/mL and desalted using Dowex 50WX4 resin (mesh size 100-200, Sigma), adding pyridine until the pH reached a value of ∼6, as previously described [28] . The solution was reduced and excess pyridine was eliminated using a rotary evaporator (Buchi) before being flash frozen and lyophilized to yield heparin pyridinium salts. The heparin pyridinium salts were then dissolved in solution of 90% DMSO/10% ddH 2 O (v/v) at a concentration of 1mg/mL. The solution was mixed for 2h at 50°C in a rotary evaporator and then cooled on ice and precipitated by an equal volume of 95% ethanol (VWR) saturated with sodium acetate (VWR). The precipitate was centrifuged and washed with ethanol prior to dissolving in distilled water (dH 2 O). The solution was dialyzed for 3 days with daily exchanges of dH 2 O and then lyophilized (Labconco). Finally, the product was functionalized using a 8.0 molar excess of of N-(3-aminopropyl) methacrylamide hydrochloride (APMAm, Polysciences), N-hydroxysuccinimide (NHS, Acros Organics) and N-3dimethylaminopropyl)-N'-ethylcarbodiimide hydrochloride (EDC, Sigma) at an acidic pH. After functionalization, the solution was dialyzed and lyophilized again as described previously. The finished product was stored at -20°C until use.
PEG-DA synthesis
Distilled methylene chloride (DCM) was used to dissolve 3.4 kDa PEG in a three neck round-bottom flask and stirred under nitrogen flow. First, triethylamine in DCM at a 1:1 molar ratio with the PEG was added. Subsequently, a 100% molar excess of acryloyl chloride (AcCl) in 15-20mL of DCM was added dropwise. Following the AcCl addition, the system was closed and kept under nitrogen overnight. Potassium carbonate (K 2 CO 3 ) was then added to the solution to remove trimethylamine hydrochloride by-product created in the previous step. After separation of the organic phase, the PEG-DA was precipitated using cold diethyl ether and dried overnight at RT. The finished product was stored at -20°C until use.
Hydrogel fabrication
PEG-DA and N-desulfated heparin (Hep -N ) were used as a mixture of 90:10 by weight in all hydrogels. These polymers were UV sterilized and combined at a 10 wt% total solution ratio with sterile phosphate buffered saline (PBS), thermal initiators ammonium persulfate (APS, 0.018M, Sigma) and N,N,N′;,N′-tetramethylethane-1,2-diamine (TEMED, 0.018M, Sigma), and an amount of GMP-quality bovine serum albumin (BSA, Sigma #A8412) equivalent to 50 wt% of the solution. The solution was then pipetted between two sterile glass slides with an inner clearance of 500μm. The solution was allowed to gel at 37°C for 10 min before the gels were punched out using a 2mm (diameter) biopsy punch (Miltex). The resulting hydrogels were discs of 0.5mm thickness and 2mm diameter.
NMR Analysis of heparin and PEG-DA polymers
Proton nuclear magnetic resonance ( 1 H NMR) was used to characterize the polymers used for hydrogel fabrication ( Figure S1 ). Samples of N-desulfated heparin methacrylamide (Hep -N Mam) and poly(ethylene glycol) diacrylate (PEG-DA) were diluted to a concentration of 10 mg/mL with deuterated water (D 2 O) and 1 H NMR was measured on a Bruker Avance III 400 spectrometer at 400 MHz. To determine the degree of functionalization of the Hep -N MAm derivative, first the contributions of N-acetyl protons in un-functionalized specimens were determined ( Figure S1A ). Subsequently, the ratio of protons donated by methacrylate groups was multiplied by the native N-acetyl groups from unfunctionalized samples ( Figure S1B ). The contribution of native methyl groups in nonmethacrylated material was approximately 8-9%. The degree of functionalization in Hep -N MAm was ∼20% for the in vitro assays in Figure S2 . For the characterization of PEG-DA, the presence of acrylate peaks around 5.8-6.4 ppm were observed ( Figure S1C ).
SDF-1α loading and in vitro release
Gels were placed in ultra-low binding 24-well plates and rinsed with PBS for 3h rinse prior to loading with recombinant murine SDF-1α (Peprotech) overnight at 4°C. During this time, each gel was incubated with a 10μL droplet of PBS containing 0.1μg growth factor or no protein (control gels). After loading, the wells were filled with 500μL of PBS and incubated at 37°C for the release study. PBS was exchanged at appropriate timepoints and stored at -20°C for subsequent analysis.
In vitro migration
SDF-1α loaded gels (aHep -N -SDF) or albumin loaded control gels (aHep -N ) were incubated with 650μL of Iscove's Modified Dulbecco's Medium (Fisher) containing 0.5% fatty acidfree bovine serum albumin (Fisher) for 24h at 37°C. A transwell assay was assembled by transferring hydrogel-conditioned media to the chamber below a 5μm pore size membrane, and seeding 4×10 5 cells from C57BL/6 mouse bone marrow aspirate on top. After 4h of migration at 37°C and 5% CO 2 , migrated cells were stained with DRAQ5 dye according to manufacturer's protocol (Cell Signaling Technologies). Relative migration was quantified by fluorescence intensity using an Odyssey CLx Infrared Imaging System (LI-COR Biosciences).
Chimeric mice
All animal procedures were conducted according to protocols approved by the Georgia Tech Institutional Animal Care and Use Committee. For generation of mice with chimeric EGFPlabeled bone marrow, male C57BL/6 recipient mice, 8-10 weeks of age, were lethally irradiated with a total dosage of 10.5 Gy (5.5-Gy and 5-Gy doses, 3h apart) using an x-ray source (Radsource 2000). Animals were given water supplemented with Baytril for 1 week before and 2 weeks after irradiation and bone marrow cell transplantation. Transplants were performed by injecting 1×10 7 bone marrow cells harvested from transgenic EGFP (donor) mice into the jugular vein of recipient mice under inhaled isoflurane anesthesia. Mice were allowed to recover for at least 4 weeks prior to surgery.
Dorsal skinfold window chamber
Male C57BL/6 mice aged 8-12 weeks of age were anesthetized by i.p. injection of a mixture of ketamine (100mg/kg) and xylazine (10mg/kg) in sterile 0.9% saline and surgically fitted with sterile dorsal skinfold window chambers (APJ Trading Co.) as previously described [17, 19, 39, 40] . Briefly, dorsal skin was shaved, depilated, and sterilized via triplet washes of 70% ethanol and chlorhexidine. A double-layered skin fold was elevated off the back of the mouse and the back side of the titanium window chamber frame was surgically fixed to the underside of the skinfold. Surgical microscissors were used to remove the epidermis and dermis from the top-side of the skinfold in a circular area (diameter = 12mm) to reveal the vasculature underlying the reticular dermis. Exposed tissue was kept hydrated with sterile saline. The front side of the titanium frame was then mounted on the top of the dissected tissue and attached to its underlying counterpart. The dorsal skin was sutured to the two titanium frames, and the exposed tissue was sealed with a protective sterile glass coverslip. Mice were allowed to recover in heated cages and administered sustained release buprenorphine via i.p. injection as a postoperative analgesic. All mice received a laboratory diet and water ad libitum throughout the course of the experiment.
Hydrogel placement and intravital brightfield microscopy
Hydrogels were implanted into the window chamber on the day of surgery (day 0). Mice were anesthetized via inhaled isoflurane, the glass window was removed and dorsal tissue was flooded with 1mM adenosine in Ringer's solution to maximally dilate all vessels and maintain tissue hydration. The mouse was then mounted to a custom microscope stage mount and imaged noninvasively at 5× magnification on a Zeiss Imager.D2 microscope with AxioCam MRc 5 color digital camera (Carl Zeiss). Images were acquired on day 0 immediately preceding hydrogel implantation and again on day 3 or 7 according to experimental design. Mice were implanted with one Hep -N internal control hydrogel and one aHep -N experimental hydrogel (unloaded or loaded with SDF-1α) placed on opposite sides of the window.
Changes in microvascular length density
Microvascular length density measurements were made by intravital brightfield microscopy and whole mount immunofluorescence. A 4mm (diameter) region of interest circumscribing the hydrogel and tangential to the gel edge was selected as indicated in Figure S4 . Vessels visible within these cropped images were traced and total vessel length per unit area was quantified using ImageJ.
Measurement of change in arteriolar diameter
To measure changes in arteriolar diameter, arteriole-venule pairs were identified within a 3mm radius of the center of each gel. Arterioles and venules were identified on the basis of size and morphology at day 0; venular diameters were larger than arteriolar diameters on day 0. Internal diameters based on blood column width in brightfield images were measured using Zen Blue (Zeiss) and recorded longitudinally for each vessel segments on day 0 and 3 or day 0 and 7 ( Figure S3 ). Day 0 diameter measurements were used to bin vessels less than 40μm in diameter [41] . This metric is limited to vessels visible at both time points (1-4 vessels/gel).
Hydrogel removal, tissue harvest, and preparation for single-cell suspensions
To visualize the recruitment of cells to the hydrogel interface, hydrogels were explanted onto glass slides and imaged at 5× magnification. For subsequent flow cytometry analysis, cells were then removed from the hydrogel surface by incubation with trypsin for 10min at 37°C and combined with a fixed volume of flow cytometry counting beads for quantification of relative cell number, CountBright™ Absolute Counting Beads (Life Technologies). To measure the recruitment of cells to tissue by day 3, the dorsal tissue was bisected along the midline separating the hydrogels, digested with 1mg/mL collagenase at 37°C, and further disaggregated with a cell strainer to create a single cell suspension.
Flow cytometry
Immuno-staining and flow cytometry analyses were performed according to standard procedures and analyzed on a FACS-AriaIIIu flow cytometer (BD Biosciences). The following antibodies were used for cell phenotyping: APC/Cy7-conjugated anti-CD11b (BioLegend, M1/70), APC-conjugated anti-Ly-6C (BioLegend, HK1.4), and PE-or PerCP/ Cy5.5-conjugated anti-CXCR4 (eBiosciences, 2B11). CD11b + SSC low Ly-6C high/low monocyte populations were confirmed to be Ly-6G neg .
Whole mount immunohistochemistry and intravital confocal microscopy
Mouse vasculature was perfused with warm 0.9% saline and then 4% PFA until tissues were fixed. Dorsal tissue was explanted and drop-fixed in 4% PFA for 10min, permeabilized with 0.2% saponin in PBS for 16-24h at 4°C, blocked with 10% mouse serum in PBS for 16-24h, and stained with combinations of the following monoclonal antibodies diluted into a solution of 0.5% BSA, 5% mouse serum, and 0.1% saponin in PBS: Cy3-conjugated anti-αsmooth muscle actin (αSMA, 1:300, Sigma), AF594-conjugated anti-CD31 (1:100, BioLegend), AF647-conjugated anti-CD68 (1:200, AbD Serotec), and AF488-conjugated anti-CD206 (1:200, AbD Serotec). Images of dorsal tissue vessel networks were acquired as 3-dimensional z-stacked tile scans in confocal and multiphoton modes using a Zeiss LSM710 NLO microscope, Ti:Sapphire pulsed IR laser, and 5×, 10×, or 20× magnification. Male heterozygous B6.129P-Cx3cr1 tm1Litt /J (CX3CR1-EGFP) mice were utilized to visualize monocytes in live mice based on their selective surface expression of CX3CR1 [7, 17] . Intravital confocal visualization of CX 3 CR1 high and CX 3 CR1 + cells in/near periimplant venules was performed in (CX3CR1-GFP) knock-in transgenic mice after jugular vein injection of rhodamine-conjugated isolectin B 4 (0.1mg/50μL; Vector Laboratories) to visualize perfused vasculature on day 1 after surgery. One 20× region of interest adjacent to each gel implant was imaged on day 1 after surgery and immediately after infusion of fluorescently tagged lectin to visualize vessels. Intravital confocal imaging was conducted with a 20× water immersion objective (NA=1.0). CX 3 CR1 + cell numbers were quantified using Fiji and 3D surface rendering was performed in Imaris (Bitplane).
Statistical analysis
Data are presented as mean ± standard error of the mean (SEM) unless otherwise indicated. Paired data for internally controlled studies were analyzed in paired t-tests or by ANOVA with repeated measures. Multiple comparisons were made by one-or two-way ANOVA followed by Bonferroni or Sidak post-tests to compare means. Linear regression analysis was performed separately on the internal control group and experimental group and r 2 values are reported. All statistical analysis was done in GraphPad Prism software. Unless otherwise noted, p<0.05 was considered statistically significant. strategy to produce a localized in vivo gradient of SDF-1α [27-29, 31, 35] . Fabrication and composition of heparin-containing hydrogels is illustrated in Figure 1A . SDF-1α release from Hep -N gels incorporating albumin was superior to release from either unmodified PEG-DA, Hep -N -PEG-DA, or albumin-PEG-DA gels ( Figure S2) ; therefore, in subsequent experiments, albumin was included in the Hep -N -PEG-DA hydrogels (aHep -N ) to improve release of SDF-1α. The albumin may help stabilize the protein from denaturation within the gel and since albumin is also negatively charged at neutral pH, may reduce growth factor binding to the gel and thus promote release [37, 38] . The albumin-containing, N-desulfated heparin-based hydrogels (aHep -N ) chosen for this study released 9.8 ± 0.1% of the loaded SDF-1α by 5h, 19.2 ± 0.1% by 24h, 23.1 ± 0.1% by day 3, and 23.8 ± 0.0% by day 7 in vitro ( Figure 1B) . Chemotaxis of primary murine bone marrow cells toward hydrogel conditioned media was analyzed to test the bioactivity of SDF-1α released from the hydrogels. Media conditioned for 24h with aHep -N -SDF gels induced a statistically significant increase in directional chemotaxis (27.22 ± 9.5%) compared to release media from the same gels with no SDF-1α (aHep -N ), indicating that SDF-1α bioactivity is retained after release from aHep -N hydrogels ( Figure 1C ).
3.2: aHep -N -SDF hydrogels locally recruit marrow-derived cells in vivo
The murine dorsal skinfold window chamber ("backpack") model enables longitudinal spatiotemporal intravital imaging of host responses to biomaterial implants including remodeling of vessel networks and coupled innate immune response [17, 19] . To evaluate the in vivo recruitment of circulating cells to the gels, we generated mouse chimeras whose bone marrow-derived hematopoietic lineage cells express a constitutive enhanced green fluorescent protein (EGFP) transgene. Chimeric mice fitted with dorsal skinfold windows permit the tracking of cells originating from the bone marrow and arriving at the injury niche. The experimental design was internally controlled to evaluate a localized biological response around the gel by implanting one aHep -N -SDF ("experimental") gel and one Hep -N ("internal control") hydrogel into opposite sides of the same window (less than 8mm separation between center of each gel) (Figure 2A, B) . Whole mount immunofluorescence microscopy analysis of dorsal skinfold tissue 2 days after surgical tissue disruption and hydrogel implantation showed that the aHep -N -SDF hydrogel appeared to recruit more bone marrow-derived (EGFP + ) circulating cells than internal control hydrogels in the same dorsal skinfold window chamber ( Figure 2C) . Moreover, the spatial distribution of recruited bone marrow-derived cells was localized to the SDF-1α implant niche, as indicated by higher trend in EGFP fluorescence underneath the SDF-1α-releasing gels compared to paired internal controls in all 3 animals (p=0.1; Figure 2C , D).
3.3: aHep -N -SDF hydrogels enhance local recruitment of anti-inflammatory monocytes
To further evaluate the identity and localization of recruited cells, wildtype C57/BL6 mice were implanted with one experimental (aHep -N or aHep -N -SDF) gel and one internal control unloaded gel (Hep -N ) as described above ( Figure 3A) . Brightfield microscopy of explanted hydrogels revealed loose cell attachment to the tissue-implant interface at day 3 with no apparent differences between groups ( Figure 3B ). Cells were digested from the surface of the gels and analyzed by flow cytometry. SDF-1α delivery did not significantly affect the number of myeloid leukocytes (CD11b + ) or cells expressing the SDF-1α receptor (CXCR4 + ) attached to the hydrogel (Figure 3B-D) . To examine the phenotypes of recruited cells in the tissue surrounding each implant, dorsal tissue was harvested and bisected along the midline separating the two hydrogels ( Figure 4A ). The proportion of CD11b + cells out of total cells in the digested dorsal tissue was not different between groups ( Figure 4B) ; however, hydrogels releasing SDF-1α significantly increased the tissue recruitment of AMs (CD11b + SSC lo Ly-6C lo ) compared to aHep -N animals ( Figure 4C ). Local infiltration of IMs (CD11b + SSC low Ly-6C high ) was not significantly different between unloaded and SDF-1αloaded aHep -N gels ( Figure 4D ). The ratio of AM to IM was significantly higher in the tissue surrounding the SDF-1α releasing hydrogels compared to both the Hep -N internal control and the aHep -N experimental control hydrogels ( Figure 4E ). To gain mechanistic insight into the preferential recruitment of AMs by SDF-1α, we analyzed the cell surface expression of the SDF-1α cognate receptor, CXCR4. Bone marrow-derived AMs have higher surface expression of CXCR4 compared to IMs ( Figure 4F ) These data suggest that the SDF-1α releasing hydrogel preferentially attracts the pro-regenerative AM subset of monocytes to the tissue surrounding the gel, which is in accordance with our previous work showing that AMs migrate toward SDF-1α significantly more than IMs [16] .
3.4: Early arteriolar vascular expansion is correlated with AM recruitment
Previous reports suggest that perivascular positioning of monocytes and macrophages promotes vascular remodeling [17, 21, 42] ; therefore we utilized intravital confocal laser microscopy analysis of post-capillary venules to examine the infiltration and positioning of CX3CR1-EGFP + monocytes ( Figure 5A , B, green) with respect to vessels ( Figure 5A , B, red) in the peri-implant region. Images were further processed with Imaris software to generate 3D surface renderings and visualize cell proximity to vessels; a 3D distance heat map was overlayed on the cells (Figure 5C, D) . Significantly more CX3CR1 + cells were observed in regions of interest around the aHep -N -SDF hydrogels on day 1 after dorsal window chamber placement ( Figure 5E ; 68 ± 17 cells (Hep -N ) vs. 127 ± 88 (aHep -N -SDF) in 0.49mm 2 area; n=3 mice). Early recruitment of CX3CR1 high AM cells was also observed (10 ± 4 cells (Hep -N ) vs. 22 ± 10 (aHep -N -SDF); n=3 mice) in agreement with our finding that SDF-1α delivery increases recruitment of AMs.
Longitudinal intravital brightfield microscopy analysis of hydrogel-treated dorsal tissue at days 0 and 3 does not show significant changes between groups in the diameter of periimplant arterioles with an initial diameter less than 40μm ( Figure 5F ); however the change in arteriolar diameter in aHep -N -SDF animals relative to the internal control was significantly higher than aHep -N relative to its internal control ( Figure 5G , n=3-4 mice per group, #p<0.05, one-way t-test). Linear regression analysis of paired immunophenotyping (by flow cytometry) and vessel measurements (by intravital imaging) indicates that arteriolar diameter enlargement positively correlates with AM:IM ratio in peri-implant tissue for both the SDF-1α-loaded and unloaded controls ( Figure 5H ). SDF-1α increased the slope of the regression line compared to unloaded gels suggesting that SDF-1α may amplify the positive effects of AM recruitment with respect to arteriolar diameter increase ( Figure 5H ).
3.5: Hydrogel release of SDF-1α sustains local arteriolar expansion and microvascular network growth
SDF-1α release maintained peri-implant arteriolar structural enlargement at day 7 ( Figure  6A-C, S3 ). All animals exhibited a positive arteriolar enlargement response to SDF-1α release from aHep -N -SDF gels compared to internal control while aHep -N gels did not differ from internal controls ( Figure 6B) . Accordingly, the change in arteriolar diameter in aHep -N -SDF relative to the internal control was significantly higher than aHep -N relative to its internal control ( Figure 6C ; -2.45% ± 10.55% (aHep -N ) vs. 24.10% ± 6.43% (aHep -N -SDF); n=3-5). We hypothesized that the sustained pro-arteriogenic response may be supported by the persistence of recruited AMs through their differentiation into macrophages, particularly of the M2 phenotype associated with regeneration [17, 43] . CD206 + M2-like macrophages were identified in a peri-arteriolar niche location ( Figure  6D ), a phenomenon previously associated with arteriogenesis [41] .
In addition to rapid changes in perfusion that can be accommodated by arteriogenic changes in local vasculature, angiogenic microvascular network growth is another hallmark of regenerative vascular remodeling. Analysis of network length in brightfield intravital microscopy was unable to detect differences in vessel length density between groups ( Figure  6E , 7A-B) perhaps due to the resolution limit of this technique (approximately 20-25μm). However, whole mount CD31 immunostaining of perfusion-fixed, explanted dorsal skin enabled visualization of capillary-level microcirculation undetectable by brightfield imaging (Figure 7C-F, S4 ). Tissue surrounding internal control hydrogels appeared to be more optically opaque in brightfield imaging ( Figure S3 ), possibly indicating the formation of granulation tissue that may obscure visualization of microvessels. SDF-1α delivery from aHep -N -SDF hydrogels significantly increased the density of CD31 + vessels near the implant compared to internal control less than 8mm away in the window chamber at day 7 ( Figure 7E-G) . These data support the idea of highly localized regenerative capacity of bioactive SDF-1α released from a heparin-based hydrogel in vivo.
Discussion
Stimulating the expansion of stable vascular networks promises to improve therapeutic outcomes after ischemia, trauma, and tissue transplantation; however, engineering a therapy that potently and safely promotes vascularization remains an unmet clinical need. Spatial concentration of pro-angiogenic/arteriogenic therapies would minimize off-target risks such as stimulating rogue tumor vasculature [44, 45] , while focusing treatment only to the injured or regenerating tissue region. Here we exploited the ability of PEG-DA hydrogels functionalized with N-desulfated heparin, a modified GAG, to localize the presentation of bioactive growth factor cargo SDF-1α [28] and spatially concentrate its pro-angiogenic/ arteriogenic effects. Selectively desulfated heparin exhibits low anticoagulant activity compared to native heparin while still protecting bioactivity of growth factor cargo [28, 29, 31, 35] .
SDF-1α is of interest in angiogenic/arteriogenic therapies because pathophysiologically, SDF-1α can be secreted perivascularly by vessel-associated cells downstream of VEGF signaling, contributing to positioning of monocytes within a localized gradient of SDF-1α at the outer vessel wall [21] . While recruitment of monocytes has been associated with proangiogenic and arteriogenic metrics [17, 21, 25, 42, [46] [47] [48] , the phenotype of SDF-1αrecruited cells has not been well characterized. Literature strongly associates both arteriogenesis and angiogenesis with recruitment of Ly-6C lo AMs and M2-like macrophages [17, 19, 49, 50] . We found that AMs have higher surface expression of CXCR4 ( Figure 4F) , therefore yielding them more sensitive to SDF-1α chemotactic signals compared to IMs. These data are in agreement with our recent finding that SDF-1α-directed chemotaxis is higher for AMs than IMs [17] . Indeed, in the present study we showed that heparinfunctionalized hydrogels exhibiting in vitro release of SDF-1α over 3 days achieved increased monocyte recruitment to the peri-hydrogel space in vivo as early as 1 day compared to internal control ( Figure 5E ). Three days after surgery, more AMs were recruited to the aHep -N -SDF gel than the aHep -N gel without SDF-1 ( Figure 4C) . Similarly, the ratio of AM to IM cells was significantly higher under the aHep -N -SDF gel compared to the Hep -N gel less than 8mm away indicating a shift in the local tissue environment from inflammatory to regenerative ( Figure 4E ). These data suggest that the aHep -N -SDF hydrogel achieves a high degree of spatial control in pro-regenerative endogenous cell recruitment that enables continued cellular therapeutic action outlasting SDF-1α release.
Monocytes and monocyte-derived macrophages are key players in promoting angiogenesis and arteriogenesis, making them a desirable endogenous cell source to target for proregenerative immunologically smart biomaterials. During inflammatory vascular remodeling, select populations of perivascular monocytes and macrophages contribute paracrine signals to the remodeling vasculature, including secretion of growth factors such as platelet-derived growth factor (PDGF) and VEGF, as well as matrix-remodeling enzymes such as MMPs [21, 25, 42, 47, 48] . Consistent with this supportive role of monocytes and macrophages in vascular remodeling, we showed in the present study that SDF-1α-releasing aHep-N hydrogels promoted the influx and retention of pro-regenerative monocytes that correlated with enhanced early and sustained arteriogenesis of small arterioles (< 40μm) and enhanced microvascular network density in the tissue surrounding SDF-1α releasing aHep -N -SDF hydrogels (Figure 4-7) . Thus, localized SDF-1α delivery may increase blood flow critical for tissue repair processes, in part through early and selective recruitment of pro-regenerative monocytes. Intravital imaging allowed us to use paired data of change in vessel diameter and immunophenotype of monocytes around the gels. Early arteriolar structural changes correlated with the AM:IM ratio in tissue and the slope of the aHep -N -SDF regression line was higher than internal control. The difference in slope between the internal control and aHep -N -SDF gels could suggest that local SDF-1α further enhances the pro-arteriogenic activity of recruited AMs locally through additional functional cues. Indeed, previous reports have suggested that VEGF induces "on-site education" of monocytes upon recruitment, functioning both as a recruitment signal and a knob to tune pro-regenerative function of the arriving cells [25] . Taken together, our data suggest that the aHep -N -SDF hydrogel system is a promising "immune-regenerative engineering" approach to promote vascularization in injured tissue through recruitment of anti-inflammatory monocytes to the injury niche to enable or enhance their therapeutic potential. 
